Solar Pharma: Solar Pharma’s Q2 nos draw value upgrades, inventory hits 7-yr excessive
Mumbai: Higher-than-expected second-quarter earnings by , coupled with a robust commentary, resulted in a pointy upward revision in earnings and value forecasts by analysts.
Shares of India's largest pharmaceutical firm, which surged to…